Use of the MiniMed advanced hybrid closed-loop (AHCL) system with different insulins (faster-acting insulin aspart and insulin aspart) did not significantly alter the risk of nocturnal hypoglycaemia on exercise days compared with non-exercise days [33, 52]. The gene discussed is INS; the disease is Hypoglycemia.